BIBDX | EPSIX | BIBDX / EPSIX | |
Total Expense Ratio | 0.80 | 1.17 | 68% |
Annual Report Gross Expense Ratio | 0.80 | 1.18 | 68% |
Fund Existence | 17 years | 16 years | - |
Gain YTD | 7.071 | 9.331 | 76% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 2000000 | 2500 | 80,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.02B | 775M | 132% |
Annual Yield % from dividends | 1.34 | 1.97 | 68% |
Returns for 1 year | 3.53 | 7.93 | 45% |
Returns for 3 years | 26.93 | 39.60 | 68% |
Returns for 5 years | 23.54 | 67.31 | 35% |
Returns for 10 years | 29.76 | 41.39 | 72% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 65.07 | -0.41 | -0.63% |
Janus Henderson Global Life Sciences A | |||
VIGIX | 215.36 | -2.91 | -1.33% |
Vanguard Growth Index Institutional | |||
FDIGX | 85.04 | -1.18 | -1.37% |
Fidelity Advisor Consumer Staples I | |||
NBMIX | 46.67 | -0.68 | -1.44% |
Neuberger Berman Small Cap Growth Inv | |||
MSAYX | 22.55 | -0.39 | -1.70% |
Morgan Stanley Inst Asia Opp R6 |